Extended Data Fig. 7: Gating strategy for B cells treated with BTKi.
From: Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury
a) Gating strategy for B cells. (b) Representative plots of LTβ+CD19+B220+ B cells from naive SJL/J splenocytes either unstimulated or stimulated with mouse anti-CD40 (5ug/ml) + LPS (1ug/ml) ex vivo after pre-treatment with BTKi (10 nM) or equivalent Vol of culture medium for 1 h.
